AC Immune stock jumps 20% on data for Parkinson's disease drug
AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
AC Immune’s Promising Trial Results for Parkinson’s Therapy
AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...
Epilepsy Society21h
Health minister responds to call for review of medicines supply chain
The Epilepsy Society was pleased to receive a reply from Health Minister, Karin Smyth in response to our letter calling for a top-to-toe review of the.
Nanowerk21h
Nanodiamonds bring new hope for Parkinson's research with advanced neuronal sensing
Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...
Nottinghamshire Live on MSN7h
Nightmares could be a symptom of serious illnesses like Parkinson's or heart problems
Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...
Slow editing of protein blueprints leads to cell death, spliceosome study discovers
An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...
So Mike Tyson is fighting a man less than half his age. Is this a really bad idea?
Some warn that Mike Tyson is at a higher risk of injury - or worse - because his age has affected his ability to react ...
Researchers use cerebrospinal fluid to unlock pathways in Alzheimer's disease
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...
FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...